INTELLIGENCE: AMICUS THERAPUTICS JUMPS 23%, SEVEN POTENTIAL BIOTECH BUYOUT TARGETS $FOLD $BMRN $EXEL $INCY $MDVN $RARE $SGEN $TSRO
This post was just published on ZYX Buy Change Alert. FOLD plans to submit a new drug application to FDA for the oral precision medicine migalastat for Fabry disease. The stock is jumping on the news. We are not recommending buying FOLD here but it can be part of a basket on